A nationwide survey of rapidly progressive glomerulonephritis in Japan: Etiology, prognosis and treatment diversity

Clinical and Experimental Nephrology

Volumn 13, Issue 6, 2009, Pages 633-650

  Koyama, Akio ^a   Yamagata, Kunihiro ^b   Makino, Hirofumi ^c   Arimura, Yoshihiro ^d   Wada, Takashi ^e   Nitta, Kosaku ^f   Nihei, Hiroshi ^f   Muso, Eri ^g   Taguma, Yoshio ^h   Shigematsu, Hidekazu ⁱ   Sakai, Hideto ^j   Tomino, Yasuhiko ^k   Matsuo, Seiichi ^l  

^a Ibaraki Prefuctural University   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g Kitano Hospital   (Japan)

^h Sendai Shakaihoken Hospital   (Japan)

ⁱ SHINSHU UNIVERSITY   (Japan)

^j TOKAI UNIVERSITY   (Japan)

^k JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Anti neutrophil cytoplasmic antibody (ANCA); Microscopic polyangiitis (MPA); Myeloperoxidase (MPO); Rapidly progressive glomerulonephritis (RPGN); Renal vasculitis; RPGN clinical grading system

Indexed keywords

CREATININE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CAUSE OF DEATH; CHILD; CLINICAL TRIAL; GLOMERULONEPHRITIS; HUMAN; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CREATININE; GLOMERULONEPHRITIS; HUMANS; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 76249092630     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0201-7     Document Type: Article

References (29)

1. Simon P, Ramee MP, Autuly V, Laruelle E, Charasse C, Cam G, et al. Epidemiology of primary glomerular diseases in a French region. Variations according to period of age. Kidney Int. 1994;46:1192-8. (Pubitemid 24319961)
2. Levy JB, Winearls CG. Rapidly progressive glomerulonephritis: what should be first-line therapy? Nephron. 1994;67:402-7. (Pubitemid 24219860)
3. Fuiano G, Cameron JS, Raftery M, Hratley BH, Williams DG, Ogg CS. Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol Dial Transplant. 1988;3:383-91.
4. Haas M, Spargo BH, Wit EJ, Meehan SM. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis. 2000;35:433-47.
5. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:23-32. (Pubitemid 26067088)
6. Satchell SC, Nicholls AJ, D'Souza RJ, Beaman M. Renal vasculitis: increasingly a disease of the elderly? Nephron Clin Pract. 2004;97:C142-6. (Pubitemid 39179247)
7. Sakai H, Kurokawa K, Koyama A, Arimura Y, Kida H, Shigematsu S, et al. Clinical guildeline for rapidly progressive glomerulonephritis in Japan. Jpn J Nephrol. 2002;44:55-82. (Pubitemid 34456622)
8. Glassock RJ, Cohen RH, Adler SG. Rapidly progressive glomerulonephritis. In: Brenner BM, editor. The kidney. Philadelphia: Saunders Co., 1996:1402-1421.
9. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis. 1988;11:449-64.
10. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed). 1982;285:606. (Pubitemid 12042688)
11. Gallagher H, Kwan JTC, Jayne DR. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis. 2002;39:42-7. (Pubitemid 34062494)
12. Falk RJ, Jennette JC. Anti-neutrophic cytoplasmic autoantibodies with specificity for myeloperoxydase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988;318:1651-7.
13. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164-77. (Pubitemid 36315601)
14. Franssen C, Stegeman C, Kallenberg C, Gans R, Jong P, Hoornije S, et al. Antipreteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57:2195-206.
15. Yashiro M, Muso E, Itoh-Ihara T, Oyama A, Hashimoto K, Kawamura T, et al. Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis. 2000;35:889-95. (Pubitemid 30238202)
16. Wichmann I, Sanchez-Roman J, Morales J, Castillo MJ, Ocana C, Nunez-Roldan A. Antimyeloperoxidase antibodies in individuals with occupational exposure to silica. Ann Rheum Dis. 1996;55:205-7. (Pubitemid 26078010)
17. Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016-22.
18. Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H, et al. The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin Immunol. 2000;94:9-12. (Pubitemid 30026906)
19. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol. 2003;30:1534-40. (Pubitemid 36835452)
20. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44:666-75. (Pubitemid 32234626)
21. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776-84. (Pubitemid 36396745)
22. Yamagata K, Hirayama K, Mase K, Yamaguchi N, Kobayashi M, Takahashi H, et al. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN. J Clin Apher. 2005;20:244-51.
23. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis. 2003;41:539-49. (Pubitemid 36278370)
24. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80-9. (Pubitemid 34075133)
25. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med. 1994;87:671-8. (Pubitemid 24334817)
26. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007;CD005590.
27. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44. (Pubitemid 36765101)
28. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol. 1999;10:1965-71. (Pubitemid 29402518)
29. Hirayama K, Kobayashi M, Hashimoto Y, Usui J, Shimizu Y, Hirayama A, et al. Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis. Am J Kidney Dis. 2004;44:57-63. (Pubitemid 38880927)